Stay updated on Pembrolizumab & Blinatumomab in ALL Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Blinatumomab in ALL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Blinatumomab in ALL Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    New help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) have been added, and a recruitment status note indicates no longer looking for participants. The Interventions header has been standardized to Intervention/Treatment, and the revision tag has been updated from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-13T05:11:20.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page's revision label updated from v3.5.4 to v3.5.5, indicating a minor version update to the page's documentation rather than a substantive change to the study content. This update does not modify any study details, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2026-06-05T21:41:09.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    The revision label on the page changed from v3.5.3 to v3.5.4. This reflects a minor site revision without altering the displayed content.
    Difference
    0.1%
    Check dated 2026-05-15T14:45:53.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    A Publications subsection was added to the Study Record, listing the article 'Immunotherapy in B-Cell Acute Lymphoblastic Leukemia' by Davis KL et al. with DOI 10.6004/jnccn.2025.7067, and noting that publications are automatically filled from PubMed.
    Difference
    0.3%
    Check dated 2026-05-08T11:44:06.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page’s footer revision label was updated from v3.5.2 to v3.5.3, reflecting a site/application version change without altering the study details.
    Difference
    0.1%
    Check dated 2026-04-24T06:27:55.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Site revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:48:44.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Blinatumomab in ALL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Blinatumomab in ALL Clinical Trial page.